Terri Davidson, PharmD | Authors

faculty of medical sciences

Sabzevar Faculty of medical sciences

Articles

Pharmacology, Pharmacokinetics, and Practical Applications of Bortezomib

December 01, 2004

Bortezomib (PS-341, Velcade) is a novel, first-in-class proteasomeinhibitor with antitumor activity against a number of hematologic andnonhematologic malignancies.